Uptake of risk consultation appointment breast cancer preventive medicines and additional mammography
breast cancer
BREAST CANCER
Attendance at risk feedback appointments was also lower than expected with 80/197 (40.6%) of high risk and 68/379 (17.9%) of women assessed at moderate risk taking up the offer of an appointment. However, the uptake of BCPM amongst women accepting a risk appointment was high (Table Uptake of risk consultation appointments, breast cancer preventive medicines (BCPM) and additional mammography screening.